Medical Digest & Congress Report

Professor Daniel Jones joins a panel of distinguished specialists to provide expert commentary on the 2025 High Blood Pressure Guideline, focusing on evidence-based strategies for clinical implementation at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:2025-high-blood-pressure-guideline

Professor Gregory Piazza provides an expert overview of the newly released 2026 Acute Pulmonary Embolism Guideline, focusing on critical updates in diagnosis and management at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:acute-pulmonary-embolism-guideline-2026

Professor Keith C. Ferdinand joins a panel of experts to discuss the practical implementation and clinical implications of the 2025 High Blood Pressure Guideline at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:meet-experts-2025-high-blood-pressure-guideline

Dr. Luke Laffin presents the results of the Kardinal Phase 2 study, investigating the efficacy of Tonlamarsen as a novel treatment option for patients with uncontrolled hypertension at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:kardinal-phase-2-study-tonlamarsen-treatment-uncontrolled-hypertension

Prof. Stanislav Henkin and Prof. Daniella Kadian-Dodov lead a comprehensive, case-based exploration of pulmonary embolism management in 2026, tracking the patient journey from initial diagnosis through to long-term recovery strategies at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:pulmonary-embolism-2026-case-based-journey-diagnosis-recovery

Professor Joseph William Rossano presents the highly anticipated results from the Phase 3 Scout-HCM trial, evaluating the efficacy and safety of Mavacamten in symptomatic adolescent patients living with obstructive hypertrophic cardiomyopathy at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:mavacamten-symptomatic-adolescent-patients-obstructive-hcm-results-phase-3-scout-hcm-trial

Professor Roxana Mehran addresses the critical need for gender-specific approaches in cardiovascular care, discussing strategies and clinical advancements aimed at saving women's hearts at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:saving-womens-hearts

Professor Carol F. Kirkpatrick highlights the most critical updates and clinical recommendations from the 2026 ACC/AHA Dyslipidemia Guideline, focusing on new management targets and therapeutic strategies for lipid disorders at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:highlights-2026-accaha-dyslipidemia-guideline

Professor Peter P. Toth provides a comprehensive update on the latest pharmacological strategies in cardiac prevention, specifically focusing on the evolving roles of hypertension management and incretin-based therapies at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:update-cardiac-prevention-medications-hypertension-and-incretin-focus

Professor Steven E. Nissen presents a critical analysis of the SURPASS-CVOT data, comparing the effects of Tirzepatide and Dulaglutide on expanded cardiorenal outcomes in patients at high cardiovascular risk at the ACC 2026 Annual Congress.

Video: https://medicaldigest.org/scientific-contents/interview:effects-tirzepatide-vs-dulaglutide-cardiorenal-outcomes-surpass-cvot-analysis